Crossref
A Novel H2S-Releasing Ibuprofen Derivative (EV-34) with Special Release KineticS Mitigates Doxorubicin-Induced Cardiac Injury
Nitric Oxide · 2026-07 · 163 · S10
DOI: 10.1016/j.niox.2026.05.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nitric Oxide, 2026-07. Verfasst von Simon Eskeif und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Eskeif, S., Gyöngyösi, A., Ambrus, L. K., Fenyvesi, F., Herczegh, P., Borbás, A., Bereczki, I., & Lekli, I. (2026). A Novel H2S-Releasing Ibuprofen Derivative (EV-34) with Special Release KineticS Mitigates Doxorubicin-Induced Cardiac Injury. Nitric Oxide, 163, S10. https://doi.org/10.1016/j.niox.2026.05.017
Vancouver
Eskeif S, Gyöngyösi A, Ambrus LK, Fenyvesi F, Herczegh P, Borbás A, et al. A Novel H2S-Releasing Ibuprofen Derivative (EV-34) with Special Release KineticS Mitigates Doxorubicin-Induced Cardiac Injury. Nitric Oxide. 2026;163:S10. doi:10.1016/j.niox.2026.05.017
BibTeX
@article{Eskeif2026,
author = {Eskeif, Simon and Gyöngyösi, Alexandra and Ambrus, Lídia Kardosné and Fenyvesi, Ferenc and Herczegh, Pál and Borbás, Anikó and Bereczki, Ilona and Lekli, István},
title = {A Novel H2S-Releasing Ibuprofen Derivative (EV-34) with Special Release KineticS Mitigates Doxorubicin-Induced Cardiac Injury},
journal = {Nitric Oxide},
year = {2026},
volume = {163},
pages = {S10},
doi = {10.1016/j.niox.2026.05.017}
}
EUVIMED